J Acute Care Surg.
2018 Apr;8(1):33-37. 10.17479/jacs.2018.8.1.33.
Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
- Affiliations
-
- 1Department of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Korea. ssulyh@gmail.com
- 2Department of Anesthesiology and Pain Medicine, Chungbuk National University Hospital, Cheongju, Korea.
- KMID: 2434954
- DOI: http://doi.org/10.17479/jacs.2018.8.1.33
Abstract
- The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have been developed to solve these problems. This paper presents a case of adaptation of NOAC for a warfarin anticoagulated patient with traumatic ongoing hemorrhages with a discussion of the clinical implications of NOAC.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Warfarin-induced Mesenteric Bleeding and Small Bowel Necrosis
- Spontaneous Intracerebral Hemorrhage: Management
- New oral anticoagulants
- Delayed bleeding after implant surgery in patients taking novel oral anticoagulants: a case report
- Sonographic Diagnosis of Fetal Intracranial Hemorrhage in a Gravida on Warfarin Therapy
